Antonio Garcia Garcia

Affiliations: 
Pharmacology Universidad Autónoma de Madrid, Madrid, Comunidad de Madrid, Spain 
Area:
electrophysiology or excitable cells
Google:
"Antonio Garcia"
Mean distance: 17.04 (cluster 28)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Torres-Rico M, García-Calvo V, Gironda-Martínez A, et al. (2024) Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7. Cell Calcium. 123: 102928
Maneu V, Borges R, Gandía L, et al. (2023) Forty years of the adrenal chromaffin cell through ISCCB meetings around the world. Pflugers Archiv : European Journal of Physiology
Fernández A, Martínez-Ramírez C, Gómez A, et al. (2023) Mitochondrial dysfunction in chromaffin cells from the R6/1 mouse model of Huntington's disease: Impact on exocytosis and calcium current regulation. Neurobiology of Disease. 106046
Padín JF, Maroto M, Entrena JM, et al. (2022) Small synthetic hyaluronan disaccharide BIS014 mitigates neuropathic pain in mice. The Journal of Pain
de Pascual R, Calzaferri F, Gonzalo PC, et al. (2021) Novel Purine Derivative ITH15004 Facilitates Exocytosis through a Mitochondrial Calcium-Mediated Mechanism. International Journal of Molecular Sciences. 23
Garrosa-Jiménez J, Sánchez Carro Y, Ovejero-Benito MC, et al. (2021) Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder. Neuroscience Letters. 765: 136275
Calzaferri F, Narros-Fernández P, de Pascual R, et al. (2021) Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation. Journal of Medicinal Chemistry
Martínez-Ramírez C, Gil-Gómez I, G de Diego AM, et al. (2020) Acute reversible SERCA blockade facilitates or blocks exocytosis, respectively in mouse or bovine chromaffin cells. Pflugers Archiv : European Journal of Physiology
Calzaferri F, Ruiz-Ruiz C, de Diego AMG, et al. (2020) The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases. Medicinal Research Reviews
de Diego AMG, Ortega-Cruz D, García AG. (2020) Disruption of Exocytosis in Sympathoadrenal Chromaffin Cells from Mouse Models of Neurodegenerative Diseases. International Journal of Molecular Sciences. 21
See more...